CLBS
insider transactionsCALADRIUS BIOSCIENCES, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
SVP, Fin/Treas, Chief Actg Off
$0
7.0K sh
Own New
-
Other·F
SVP, Fin/Treas, Chief Actg Off
$1.5K
781 sh · $1.97
Own -2%
-
Grant·A
SVP, Fin/Treas, Chief Actg Off
$0
15.0K sh
Own +64%
-
Other·F
SVP, Fin/Treas, Chief Actg Off
$4.2K
2.1K sh · $1.97
Own -6%
-
Other·F
SVP, Fin/Treas, Chief Actg Off
$4.2K
2.1K sh · $1.97
Own -6%
-
Other·F
SVP, Fin/Treas, Chief Actg Off
$2.2K
1.1K sh · $1.97
Own -3%
-
Grant·A
SVP, Bus Dev, General Counsel
$0
7.0K sh
Own New
-
Other·F
SVP, Bus Dev, General Counsel
$1.5K
747 sh · $1.97
Own -2%
-
Grant·A
SVP, Bus Dev, General Counsel
$0
15.0K sh
Own +61%
-
Other·F
SVP, Bus Dev, General Counsel
$2.8K
1.4K sh · $1.97
Own -4%
-
Other·F
SVP, Bus Dev, General Counsel
$1.7K
840 sh · $1.97
Own -2%
-
Other·F
SVP, Bus Dev, General Counsel
$1.0K
513 sh · $1.97
Own -1%
-
Grant·A
EVP, R&D and CMO
$0
13.0K sh
Own New
-
Other·F
EVP, R&D and CMO
$6.3K
3.2K sh · $1.97
Own -3%
-
Other·F
EVP, R&D and CMO
$5.9K
3.0K sh · $1.97
Own -3%
-
Other·F
EVP, R&D and CMO
$4.2K
2.1K sh · $1.97
Own -2%
-
Grant·A
EVP, R&D and CMO
$0
25.0K sh
Own +31%
-
Other·F
EVP, R&D and CMO
$5.9K
3.0K sh · $1.97
Own -3%
-
Grant·A
Director
$0
30.5K sh
Own +47%
-
Grant·A
Director
$0
30.5K sh
Own +55%
-
Grant·A
Director
$0
30.5K sh
Own +41%
-
Grant·A
Mazzo David J KEY
President & CEO
$0
40.0K sh
Own New
-
Grant·A
Mazzo David J KEY
President & CEO
$0
81.0K sh
Own +30%
-
Other·F
Mazzo David J KEY
President & CEO
$20.7K
10.5K sh · $1.97
Own -3%
-
Other·F
Mazzo David J KEY
President & CEO
$20.7K
10.5K sh · $1.97
Own -3%
-
Other·F
Mazzo David J KEY
President & CEO
$15.5K
7.9K sh · $1.97
Own -2%
-
Other·F
Mazzo David J KEY
President & CEO
$24.1K
12.2K sh · $1.97
Own -4%
-
Grant·A
Director
$0
30.5K sh
Own +47%
-
Grant·A
Director
$0
30.5K sh
Own +47%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | Nisco James | Grant A | 7.0K | $0 |
| Jan 9, 2026 | Nisco James | Other F | 781 | $1.5K |
| Jan 9, 2026 | Nisco James | Grant A | 15.0K | $0 |
| Jan 9, 2026 | Nisco James | Other F | 2.1K | $4.2K |
| Jan 9, 2026 | Nisco James | Other F | 2.1K | $4.2K |
| Jan 9, 2026 | Nisco James | Other F | 1.1K | $2.2K |
| Jan 9, 2026 | Imam Tariq | Grant A | 7.0K | $0 |
| Jan 9, 2026 | Imam Tariq | Other F | 747 | $1.5K |
| Jan 9, 2026 | Imam Tariq | Grant A | 15.0K | $0 |
| Jan 9, 2026 | Imam Tariq | Other F | 1.4K | $2.8K |
| Jan 9, 2026 | Imam Tariq | Other F | 840 | $1.7K |
| Jan 9, 2026 | Imam Tariq | Other F | 513 | $1.0K |
| Jan 9, 2026 | Buck Kristen K | Grant A | 13.0K | $0 |
| Jan 9, 2026 | Buck Kristen K | Other F | 3.2K | $6.3K |
| Jan 9, 2026 | Buck Kristen K | Other F | 3.0K | $5.9K |
| Jan 9, 2026 | Buck Kristen K | Other F | 2.1K | $4.2K |
| Jan 9, 2026 | Buck Kristen K | Grant A | 25.0K | $0 |
| Jan 9, 2026 | Buck Kristen K | Other F | 3.0K | $5.9K |
| Jan 9, 2026 | Schwalm Cynthia | Grant A | 30.5K | $0 |
| Jan 9, 2026 | HENSON HEIDI | Grant A | 30.5K | $0 |
| Jan 9, 2026 | AZAB MOHAMMAD | Grant A | 30.5K | $0 |
| Jan 9, 2026 | Mazzo David J KEY | Grant A | 40.0K | $0 |
| Jan 9, 2026 | Mazzo David J KEY | Grant A | 81.0K | $0 |
| Jan 9, 2026 | Mazzo David J KEY | Other F | 10.5K | $20.7K |
| Jan 9, 2026 | Mazzo David J KEY | Other F | 10.5K | $20.7K |
| Jan 9, 2026 | Mazzo David J KEY | Other F | 7.9K | $15.5K |
| Jan 9, 2026 | Mazzo David J KEY | Other F | 12.2K | $24.1K |
| Jan 9, 2026 | BROWN GREGORY B | Grant A | 30.5K | $0 |
| Jan 9, 2026 | KLOSK STEVEN M | Grant A | 30.5K | $0 |
About CLBS insider trading
This page tracks insider transactions for CALADRIUS BIOSCIENCES, INC. (CLBS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.